What is the address of SCB SURGERY?

The registered office of SCB SURGERY is located at Rijkenhoekstraat 38, 3191 Boortmeerbeek.

Is SCB SURGERY still active?

Yes. According to the CBE (2 November 2026) SCB SURGERY is active, legal situation “Normale toestand”, started on 26 December 2019.

Is SCB SURGERY registered on Peppol?

Yes, SCB SURGERY is registered on the Peppol network with ID 0208:0740497406.

What is the enterprise number of SCB SURGERY?

The enterprise number of SCB SURGERY is BE0740497406.

When was SCB SURGERY founded?

SCB SURGERY was founded on 26 December 2019.

Who are the directors of SCB SURGERY?

According to the 2025 annual accounts, the directors of SCB SURGERY are: Luis Carlos Silva Corten.

Is SCB SURGERY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SCB SURGERY make in 2025?

SCB SURGERY posted a profit after taxes of € 101,021 in financial year 2025.

What is the revenue of SCB SURGERY?

As a small company, SCB SURGERY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 132,833.

SCB SURGERY (Private Limited) - Boortmeerbeek

Dossier SCB SURGERY, printed on 2 November 2026 from databakkes.be/en/0740497406/scb-surgery. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SCB SURGERY from Boortmeerbeek, company number BE0740497406, closed financial year 2025 with a result of € 101,021 after tax. For that financial year SCB SURGERY recorded a gross margin of € 132,833 and equity of € 5,000. Compared with financial year 2024, the result moved from € 70,208 to € 101,021. Profitable, and profit is growing. The buffer shrank hard: equity is 93 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Shrank hard

€ 5,000

▼ 93% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 101,021

▲ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 63,527

▲ 199% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 171,229 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,820

▲ € 2,154 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,732

▲ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,918

▲ € 8,961 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 90,474 Gross margin 2022: € 90,474 First fiscal year in the series	€ 71,570 Gross margin 2023: € 71,570 ▼ 21% vs 2022 (€ 90,474) Unfavourable step	€ 108,094 Gross margin 2024: € 108,094 ▲ 51% vs 2023 (€ 71,570) Favourable step	€ 132,833 Gross margin 2025: € 132,833 ▲ 23% vs 2024 (€ 108,094) Favourable step	▲ 23%
Profit after taxes	€ 57,220 Profit after taxes 2022: € 57,220 First fiscal year in the series	€ 41,764 Profit after taxes 2023: € 41,764 ▼ 27% vs 2022 (€ 57,220) Unfavourable step	€ 70,208 Profit after taxes 2024: € 70,208 ▲ 68% vs 2023 (€ 41,764) Favourable step	€ 101,021 Profit after taxes 2025: € 101,021 ▲ 44% vs 2024 (€ 70,208) Favourable step	▲ 44%
Equity	€ 227,455 Equity 2022: € 227,455 First fiscal year in the series	€ 269,219 Equity 2023: € 269,219 ▲ 18% vs 2022 (€ 227,455) Favourable step	€ 75,208 Equity 2024: € 75,208 ▼ 72% vs 2023 (€ 269,219) Unfavourable step	€ 5,000 Equity 2025: € 5,000 ▼ 93% vs 2024 (€ 75,208) Unfavourable step	▼ 93%
Total debts	€ 22,015 Total debts 2022: € 22,015 First fiscal year in the series	€ 5,350 Total debts 2023: € 5,350 ▼ 76% vs 2022 (€ 22,015) Favourable step	€ 1,944 Total debts 2024: € 1,944 ▼ 64% vs 2023 (€ 5,350) Favourable step	€ 112,672 Total debts 2025: € 112,672 ▲ € 110,727 vs 2024 (€ 1,944) Unfavourable step	▲ € 110,727
Cash	€ 146,800 Cash 2022: € 146,800 First fiscal year in the series	€ 208,623 Cash 2023: € 208,623 ▲ 42% vs 2022 (€ 146,800) Favourable step	€ 21,270 Cash 2024: € 21,270 ▼ 90% vs 2023 (€ 208,623) Unfavourable step	€ 63,527 Cash 2025: € 63,527 ▲ 199% vs 2024 (€ 21,270) Favourable step	▲ 199%
Retained profit	€ 222,455 Retained profit 2022: € 222,455 First fiscal year in the series	€ 264,219 Retained profit 2023: € 264,219 ▲ 19% vs 2022 (€ 222,455) Favourable step	€ 70,208 Retained profit 2024: € 70,208 ▼ 73% vs 2023 (€ 264,219) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 70,208) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 264,219 Dividend 2024: € 264,219 Unchanged (€ 0) Unchanged	€ 171,229 Dividend 2025: € 171,229 ▼ 35% vs 2024 (€ 264,219) Unchanged	▼ 35%
Bank debt	€ 18,334 Bank debt 2022: € 18,334 First fiscal year in the series	€ 1,420 Bank debt 2023: € 1,420 ▼ 92% vs 2022 (€ 18,334) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,420) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 249,470 Balance sheet total 2022: € 249,470 First fiscal year in the series	€ 274,570 Balance sheet total 2023: € 274,570 ▲ 10% vs 2022 (€ 249,470) Unchanged	€ 77,152 Balance sheet total 2024: € 77,152 ▼ 72% vs 2023 (€ 274,570) Unchanged	€ 117,672 Balance sheet total 2025: € 117,672 ▲ 53% vs 2024 (€ 77,152) Unchanged	▲ 53%

Key figures of SCB SURGERY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SCB SURGERY?

What happened at SCB SURGERY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 101,021 (▲ 44% vs 2024). Source: NBB ↗
Dec 26, 2019 New establishment in Boortmeerbeek. KBO
2019 Luis Carlos Silva Corten became a director. NBB
Dec 26, 2019 Start of the company according to the CBE. KBO

In short

From € 57,220 profit in 2022 to € 101,021 profit in 2025.

Paid € 76,379 in corporate taxes since 2022.

Best year ever: 2025, with € 101,021 profit.

Paid out € 435,448 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Luis Carlos Silva Corten

SCB SURGERY

Behind SCB SURGERY is Luis Carlos Silva Corten.

Directors

According to the 2025 annual accounts

Luis Carlos Silva Corten

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Rijkenhoekstraat 38

3191 Boortmeerbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Proctos

€ 151,988 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0740.497.406
VAT number: BE 0740.497.406
Registered office: Rijkenhoekstraat 38, 3191 Boortmeerbeek
Names & denominations: SCB SURGERY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 December 2019
Peppol: Active · Active since 6 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗